More importantly, we provided the first evidence supporting the protective effects of RES in the setting of alcohol-induced fatty liver disease, which are consistent with previous findings, and down regulation of HIF-1α protein expression and mitochondrial ROS production in liver might be, at least part of, the underlying mechanisms. Here, HIF1A is linked to fatty liver disease.